141 related articles for article (PubMed ID: 22166449)
1. Upcoming treatments in Parkinson's disease, including gene therapy.
Rodnitzky RL
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S37-40. PubMed ID: 22166449
[TBL] [Abstract][Full Text] [Related]
2. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Parkinson's disease : what's on the horizon?
Wu SS; Frucht SJ
CNS Drugs; 2005; 19(9):723-43. PubMed ID: 16142989
[TBL] [Abstract][Full Text] [Related]
4. Preclinical development of gene therapy for Parkinson's disease.
Porras G; Bezard E
Exp Neurol; 2008 Jan; 209(1):72-81. PubMed ID: 17904121
[TBL] [Abstract][Full Text] [Related]
5. Future treatments for Parkinson's disease: surfing the PD pipeline.
Hauser RA
Int J Neurosci; 2011; 121 Suppl 2():53-62. PubMed ID: 22035030
[TBL] [Abstract][Full Text] [Related]
6. Future therapies for Parkinson's disease.
Hauser RA; Lyons KE
Neurol Clin; 2004 Oct; 22(3 Suppl):S149-66. PubMed ID: 15501363
[No Abstract] [Full Text] [Related]
7. Gene therapy for Parkinson's disease.
Bjorklund T; Kordower JH
Mov Disord; 2010; 25 Suppl 1():S161-73. PubMed ID: 20187249
[TBL] [Abstract][Full Text] [Related]
8. NLX-P101, an adeno-associated virus gene therapy encoding glutamic acid decarboxylase, for the potential treatment of Parkinson's disease.
Diaz-Nido J
Curr Opin Investig Drugs; 2010 Jul; 11(7):813-22. PubMed ID: 20571977
[TBL] [Abstract][Full Text] [Related]
9. [Gene therapy for Parkinson's disease].
Muramatsu S
Brain Nerve; 2007 Apr; 59(4):425-30. PubMed ID: 17447529
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy in Parkinson's disease.
Eberhardt O; Schulz JB
Cell Tissue Res; 2004 Oct; 318(1):243-60. PubMed ID: 15322915
[TBL] [Abstract][Full Text] [Related]
11. Management of Parkinson's disease a review of current and new therapies.
Mendis T; Suchowersky O; Lang A; Gauthier S
Can J Neurol Sci; 1999 May; 26(2):89-103. PubMed ID: 10352867
[TBL] [Abstract][Full Text] [Related]
12. New small molecules for the treatment of Parkinson's disease.
Müller T
Expert Opin Investig Drugs; 2010 Sep; 19(9):1077-86. PubMed ID: 20645881
[TBL] [Abstract][Full Text] [Related]
13. Milestones in Parkinson's disease therapeutics.
Rascol O; Lozano A; Stern M; Poewe W
Mov Disord; 2011 May; 26(6):1072-82. PubMed ID: 21626552
[TBL] [Abstract][Full Text] [Related]
14. Novel pharmacological targets for the treatment of Parkinson's disease.
Schapira AH; Bezard E; Brotchie J; Calon F; Collingridge GL; Ferger B; Hengerer B; Hirsch E; Jenner P; Le Novère N; Obeso JA; Schwarzschild MA; Spampinato U; Davidai G
Nat Rev Drug Discov; 2006 Oct; 5(10):845-54. PubMed ID: 17016425
[TBL] [Abstract][Full Text] [Related]
15. [Gene therapy and cell transplantation for Parkinson's disease].
Muramatsu S
Rinsho Shinkeigaku; 2005 Nov; 45(11):902-4. PubMed ID: 16447758
[TBL] [Abstract][Full Text] [Related]
16. [Future of gene therapy for Parkinson's disease].
Mochizuki H
Rinsho Shinkeigaku; 2004 Nov; 44(11):948-50. PubMed ID: 15651340
[TBL] [Abstract][Full Text] [Related]
17. What's in the pipeline for the treatment of Parkinson's disease?
Sommer DB; Stacy MA
Expert Rev Neurother; 2008 Dec; 8(12):1829-39. PubMed ID: 19086879
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for Parkinson's disease: from non-human primates to humans.
Fiandaca MS; Bankiewicz KS
Curr Opin Mol Ther; 2010 Oct; 12(5):519-29. PubMed ID: 20886383
[TBL] [Abstract][Full Text] [Related]
19. [Neuroprotective and neurorestorative therapy in Parkinson's disease].
Jiménez-Jiménez FJ; Molina JA
Rev Neurol; 1997 Aug; 25 Suppl 2():S185-93. PubMed ID: 9280687
[TBL] [Abstract][Full Text] [Related]
20. New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists.
Pinna A; Wardas J; Simola N; Morelli M
Life Sci; 2005 Nov; 77(26):3259-67. PubMed ID: 15979104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
